Clinical, Neuroimaging, and Genetic Markers Associated with Cognitive and Functional Outcomes After Traumatic Brain Injury
Khrystyna Duve(I.Horbachevsky Ternopil National Medical University), Oleksandr Kamyshnyi(I.Horbachevsky Ternopil National Medical University), Svitlana Shkrobot(I.Horbachevsky Ternopil National Medical University), Valentyn Oksenych(University of Bergen), Pavlo Petakh(Kyiv School of Economics)
Cited by 0
Related Papers
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
|The Lancet Neurology|2020|495
Effects of metformin on the gut microbiota: A systematic review
|Molecular Metabolism|2023|91
The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
|Biomedicine & Pharmacotherapy|2023|70
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
|Antioxidants|2024|64